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Abstract
Background: Normalization of brachial artery flow-mediated dilation (FMD) to individual shear
stress area under the curve (peak FMD:SSAUC ratio) has recently been proposed as an approach to
control for the large inter-subject variability in reactive hyperemia-induced shear stress; however,
the adoption of this approach among researchers has been slow. The present study was designed
to further examine the efficacy of FMD normalization to shear stress in reducing measurement
variability.
Methods: Five different magnitudes of reactive hyperemia-induced shear stress were applied to
20 healthy, physically active young adults (25.3 ± 0. 6 yrs; 10 men, 10 women) by manipulating
forearm cuff occlusion duration: 1, 2, 3, 4, and 5 min, in a randomized order. A venous blood draw
was performed for determination of baseline whole blood viscosity and hematocrit. The magnitude
of occlusion-induced forearm ischemia was quantified by dual-wavelength near-infrared
spectrometry (NIRS). Brachial artery diameters and velocities were obtained via high-resolution
ultrasound. The SSAUC was individually calculated for the duration of time-to-peak dilation.
Results: One-way repeated measures ANOVA demonstrated distinct magnitudes of occlusion-
induced ischemia (volume and peak), hyperemic shear stress, and peak FMD responses (all p <
0.0001) across forearm occlusion durations. Differences in peak FMD were abolished when
normalizing FMD to SSAUC (p = 0.785).
Conclusion: Our data confirm that normalization of FMD to SSAUC eliminates the influences of
variable shear stress and solidifies the utility of FMD:SSAUC ratio as an index of endothelial function.
Background
As a "barometer" for cardiovascular health status, brachial
artery flow-mediated dilation (FMD) provides a bioassay
for in vivo endothelial function [1]. The evidence support-
ing the dependency of FMD on the endothelium is based
on the observation that, after removal of the endothelial
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lining, arteries lose their ability to dilate in response to an
increase in flow [2]. Furthermore, FMD is partially to
totally abolished after intra-arterial administration of a
NO synthase blocker (i.e. L-NMMA) [3,4]. Nitric oxide is
an anti-atherosclerotic molecule, and decreased NO bioa-
vailability is a hallmark of pro-atherogenic states [5]. The
biological significance of FMD, the relative simplicity and
the non-invasive nature of the technique has motivated
the dramatic growth in FMD research over the past 15
years. The widespread adoption of this ultrasound tech-
nique has been supported in part by published data sug-
gesting that FMD correlates with invasive measurements
of endothelial function in the coronary arteries [6,7] and
may predict future cardiovascular events [8,9]. However,
data are also available indicating that reduced FMD has
weak or no association with other cardiovascular risk fac-
tors [10,11], is a questionable marker of the presence and
severity of coronary artery disease [12], fails to show a
prognostic value [13], and has poor diagnostic accuracy
for identifying older adults with subclinical cardiovascu-
lar disease [14]. These contradictory results may be due to
substantial discrepancies in FMD protocols across labs,
but also due to the inter-subject variability in hyperemic
shear stress (the stimulus for FMD). Large variability in
reactive hyperemia has been documented among individ-
uals and populations [15]. The unadjusted FMD outcome
may reflect conduit artery endothelial function as well as
the magnitude of the hyperemic stimulus. Current work is
moving to adjust the measured vasodilation response for
the applied stimulus; in other words, dividing the peak
FMD by the magnitude of stimulus achieved with reactive
hyperemia. In 2005, Pyke and Tschakovsky [15], the initi-
ators of this approach, suggested the utilization of shear
rate (or shear stress (SS)) area under the curve (SSAUC)
(individual area until peak FMD) as a method to quantify
the entire and "relevant" hyperemic stimulus; and thus to
be used for FMD normalization purposes. Two years later
[16], the same authors provided experimental evidence of
the physiological appropriateness of using this method.
They concluded that the SSAUC, but not the peak shear,
was the critical determinant of the peak FMD response.
Following publication of this paper, a radical change in
clinical practice within the FMD community was
expected; however, to our surprise, since the time of Pyke
and Tschakovsky's publication (April 2007), only two
[17,18] out of 92 FMD studies (PubMed search) have
incorporated normalization of FMD to SSAUC. Reasons for
this slow adoption of the recently proposed method to
express FMD data may include 1) insufficient lead time
after publication of the article for dissemination and
implementation; 2) inability to simultaneously capture
arterial diameter and velocity; 3) lack of clinical evidence
supporting the utility of this approach; and 4) compli-
cated comparison with the large body of evidence col-
lected using the traditional FMD approach.
A "proof of concept" study was conducted herein to fur-
ther evaluate the efficacy of FMD normalization. In a
group of healthy individuals, we elicited five different
magnitudes of reactive hyperemia-induced shear stress to
mimic real-life inter-population differences. Considering
this analogy, we created the following experimental sce-
nario: comparison of five hypothetical "populations"
with different magnitudes of reactive hyperemia-induced
shear stress stimuli. Because the five "populations" do in
fact have identical endothelial function, the correct out-
come should be no detectable differences. We hypothe-
sized that peak FMD:SSAUC  ratio (normalization
approach), but not peak FMD (traditional approach),
would be the same among the five "populations" with
identical endothelial function. This observation would
corroborate that normalization of FMD to SSAUC elimi-
nates the influences of variable shear stress found among
populations, and solidify the utility of FMD:SSAUC ratio as
an index of endothelial function.
Methods
Subjects
Twenty healthy, physically active young adults (10 men,
10 women) volunteered for this study. All subjects were
free of recognized cardiovascular, pulmonary and meta-
bolic diseases, non-hypertensive (resting blood pressure <
140/80 mm Hg), non-obese (body mass index < 30 kg/
m2), non-smokers, and had no family history of heart dis-
eases. No subjects were taking medications with vaso-
active effects, including contraceptives. All procedures
were approved by Indiana University Committee for the
Protection of Human Subjects. Written informed consent
was obtained from each subject prior to participation in
the study.
Study procedures
Procedures of the study consisted of a screening session
and a vascular testing session. The screening session
included completion of a medical history/health habits
questionnaire, measurements of height, weight, resting
blood pressure, and a fasting venous blood draw to obtain
total cholesterol, low density lipoprotein cholesterol, high
density lipoprotein cholesterol, triglycerides, blood glu-
cose, and high sensitivity C-reactive protein. In addition,
all subjects were familiarized with the equipment/testing
room to be used during the vascular session.
On the vascular session day, subjects were instructed to
report to the laboratory between 6:00 and 10:00 am hav-
ing 1) fasted for 12 h, 2) abstained from caffeine, tobacco
products, and vitamin supplements for 12 h, and 3)
abstained from exercise for 12 h [1]. Women were studied
during days 1–7 of their menstrual cycle to minimize the
influence of cyclical changes in female hormones. Sub-
jects were instructed to lie supine in a dark, climate-con-Cardiovascular Ultrasound 2008, 6:44 http://www.cardiovascularultrasound.com/content/6/1/44
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trolled quiet room (22–24°C), with their right arm
extended out laterally. A venous blood draw was per-
formed from the antecubital vein. Samples were collected
into 6-mL heparin vacutainer tubes for determination of
whole blood viscosity and hematocrit. Each subject
underwent an acclimation phase (20 min) to obtain a
hemodynamic steady state. Heart rate was continuously
monitored using a three-lead ECG. Blood pressures were
taken in the left arm with a mercury sphygmomanometer
to confirm a steady state. A 5 × 84 cm automatic cuff (E-
20 rapid cuff inflator, D.E. Hokanson, Bellevue, WA) was
placed around the forearm immediately distal to the ole-
cranon process following established guidelines for
assessing FMD [1]. To quantify the magnitude of occlu-
sion-induced ischemia (volume and peak), a dual-wave-
length near-infrared spectrometry (NIRS) (ISS,
Champaign, IL) probe was positioned over the right
extensor digitorum muscle (medial aspect, distally from
the cuff). The probe was held in place with an elastic
bandage. The forearm oxygen tissue saturation (%StO2)
was recorded throughout the study. The ultrasound image
of the brachial artery was obtained longitudinally 2–10
cm above the antecubital fossa by 2D high resolution
(Terason T3000, Teratech Corporation, Burlington, MA)
ultrasound system, using a 5 to 12-MHz multifrequency
linear-array transducer. Once a satisfactory image was
obtained, the right arm was secured using a custom-
designed arm immobilizer and the transducer was stabi-
lized using a clamp (Figure 1). Minor corrections of trans-
ducer placement were made to maintain optimal imaging.
Doppler velocity was also measured via ultrasound. Dop-
pler flow signals were corrected at an insonation angle of
60° and measurements were performed with the sample
volume placed in mid-artery. Ultrasound parameters were
not changed during the study. Simultaneous Doppler
measurements for blood velocity and 2D ultrasound
imaging for diameter were continuously recorded for 30
sec at baseline. The automatic forearm cuff was then
inflated to 250 mm Hg and maintained for 1, 2, 3, 4 or 5
min; in a randomized order. Diameter and velocity
recordings resumed before cuff deflation and continued
for 2 min thereafter. Ultrasound images were recorded at
5 frames/second using Camtasia (TechSmith, Okemos,
MI) and converted into an AVI file. R-wave gated frames
Experimental set-up Figure 1
Experimental set-up.Cardiovascular Ultrasound 2008, 6:44 http://www.cardiovascularultrasound.com/content/6/1/44
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were not captured exclusively because internal data in our
laboratory shows that continuous assessment of diameter
at 5 frames/second yields the same FMD results (n = 10;
FMD = 7.58 ± 0.9 vs. 7.62 ± 0.9%, p = 0.655; Intraclass
correlation coefficient = 0.998, p < 0.0001). The occlusion
conditions were applied 10 min apart from each other
and baseline measurements were re-established prior to
each condition.
Data analysis
Brachial Artery Diameter and Blood Velocity
Off-line analyses of diameters and velocities were per-
formed using an automated edge-detection Brachial Ana-
lyzer software (Medical Imaging Applications, LLC,
Coralville, IA); briefly, the software allows the user to
identify a region of interest (ROI) on the portion of the
image where the vessel walls are most clear. The arterial
wall borders were detected by an optimal graph search-
based segmentation that uses a combination of pixel den-
sity and image gradient as an objective function. Each
sequence of images was reviewed by the technician and
interactively edited when needed to ensure that diameter
measurements were always calculated from the intima-
lumen interface at the distal and proximal vessel wall.
Similarly, for determination of blood velocity, the ROI
was selected around the Doppler waveform and the trace
of the velocity-time integral was used to calculate mean
velocity for each cardiac cycle (Figure 2). All measure-
ments were performed by a single technician who was
blinded to the trial condition for each image sequence.
Reproducibility of our measurements has been reported
previously [19]. The time course of diameters and veloci-
ties were determined using a 3-sec moving average. The
peak dilation postocclusion was determined as the high-
est 3-sec average and was presented as a percent change
from baseline diameter (peak FMD; %). Brachial artery
blood flow was calculated using the following formula:
Vm ￿ π ￿ (D2/4) 60, where Vm is mean blood velocity (cm
￿ s-1), π is 3.14, and D is mean arterial diameter (cm) [20].
Whole blood viscosity
With the use of a pipette, 1 mL of blood sample was
removed from the vacutainer tube, the mass of the sample
was determined, and the density calculated. An additional
blood sample was removed and transferred to a glass cap-
illary viscometer [21] (Cannon-Manning Semi-Micro Vis-
cometer, Cannon Instruments, Philadelphia, PA) and
placed in a constant-temperature water bath (37°C). The
viscosity of the sample was determined by measuring the
time required for the sample to pass between two fixed
points on the viscometer. Kinematic viscosity (mm2 ￿ s-1)
was obtained by multiplying a viscometer constant
(0.007927 mm2 ￿ s-2) by the efflux time in seconds. To
obtain viscosity in mPa ￿ s, kinematic viscosity was multi-
plied by the density in grams per milliliter. Measures were
performed in duplicate.
Brachial artery shear stress
Brachial artery shear stress (dynes ￿ cm-2) was calculated
using the following formula: (4ηVm) ￿ D-1, where η is
blood viscosity (mPa ￿ s), Vm is mean blood velocity (cm
￿ s-1), and D is mean arterial diameter (cm) [22]. To
describe the magnitude of reactive hyperemia-induced
shear stress elicited with increased duration of occlusion,
shear stress AUC was calculated for each occlusion condi-
tion. Briefly, the AUC was calculated by summing the
areas of successive postocclusion trapezoids (each with a
base of 3-sec) for 60 sec (SS60secAUC; a.u.). To quantify
the "relevant" hyperemic stimulus responsible for the
peak FMD response, the shear stress AUC above baseline
Analysis of brachial diameter and velocity (using the edge- detection Brachial Analyzer software) of a representative  subject immediately following cuff deflation Figure 2
Analysis of brachial diameter and velocity (using the 
edge-detection Brachial Analyzer software) of a rep-
resentative subject immediately following cuff defla-
tion.Cardiovascular Ultrasound 2008, 6:44 http://www.cardiovascularultrasound.com/content/6/1/44
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was individually calculated for the duration of time-to-
peak dilation (SSAUC; a.u.). Normalization of FMD to
shear stress was expressed as the peak FMD:SSAUC ratio
(a.u).
Hematocrit
A 50–75 μL blood sample was removed from the vacu-
tainer tube, transferred into a capillary tube and centri-
fuged for 5 min using a micro-hematocrit centrifuge
(Clay-Adams, New York, NY). Hematocrit (%) was read
using a micro-capillary reader (International Equipment
Company, Needham Heights, MA). Measures were per-
formed in duplicate.
Magnitude of ischemia
Forearm oxygen tissue saturation (StO2; %) was moni-
tored at baseline (30 sec), throughout each occlusion
period, and during the reperfusion phase. The time course
of StO2 was determined using a 3-sec moving average. To
quantify the volume of ischemia, the StO2 AUC (area
below baseline) was calculated by summing the areas of
successive trapezoids (each with a base of 3-sec) for the
total duration of the occlusion period (StO2AUC; a.u.).
Peak ischemia (StO2peak; %) was considered as the StO2
change from baseline to immediately before cuff release.
Statistical analysis
Descriptive statistics were used to summarize the subject
demographic data. One-way repeated measures ANOVA
(5 levels) were performed to determine the effect of fore-
arm occlusion duration on volume of ischemia (StO2AUC;
a.u.), peak ischemia (StO2peak; a.u.), magnitude of reactive
hyperemia-induced shear stress (SS60secAUC; a.u.), peak
FMD response (%), and FMD normalized to shear stress
(FMD:SSAUC ratio; a.u.). Tukey's HSD procedure was used
when a significant F-ratio was found. All data are pre-
sented as mean ± standard error of the mean (SEM). For
all statistical tests, the alpha level was set at 0.05. Statisti-
cal analyses were performed with SPSS v.15.0. (SPSS, Inc.
Chicago, IL, USA).
Results
Demographic information of the subjects is summarized
in Table 1. No effect of sex was found in any of the main
outcome variables (SS60secAUC, peak FMD response,
FMD:SSAUC ratio), thus data were pooled across sex. Table
2 displays mean baseline values for brachial artery diame-
ter, blood velocity, shear stress, heart rate and forearm
oxygen tissue saturation. No differences in baseline values
were found (p > 0.05) for any of the variables. NIRS data
on one subject was lost, thus sample size was 19 for all
NIRS-related analysis. Figure 3 illustrates the time course
of forearm oxygen tissue saturation in conjunction with
brachial artery blood flow across the different forearm
occlusion conditions. As indicated, the volume of
ischemia and peak ischemia increased incrementally with
duration of forearm occlusion (F(4,72) = 102.6; p < 0.0001
and F(4,72) = 69.85; p < 0.0001, respectively). Figure 4 illus-
trates the effects of forearm occlusion duration on the
magnitude of reactive hyperemia-induced shear stress
(panel A), peak FMD response (panel B), and FMD nor-
malized to shear stress (panel C). As shown, varying fore-
arm occlusion duration effectively elicited five different
magnitudes of reactive hyperemia-induced shear stress
(F(4,76) = 97.6; p < 0.0001). As a result, differences in peak
FMD response were detected among conditions (F(4,76) =
40.5; p < 0.0001); however, these discrepancies were abol-
ished when normalizing FMD to the shear stress (peak
FMD:SSAUC ratio) (F(4,76) = 0.43; p = 0.785).
Discussion
Given that reactive hyperemia varies among individuals
and populations [15], the FMD outcome is reflective of
both conduit artery endothelial function and magnitude
of the hyperemic stimulus. Normalization of FMD to
SSAUC has recently been proposed [16] to control for the
presence of the large inter-subject variability in reactive
hyperemia-induced shear stress and solely reflect conduit
artery endothelial function. The present study was
designed to further examine the efficacy of FMD normali-
zation. In a group of healthy individuals, via manipula-
tion of duration of cuff occlusion, we evoked five different
magnitudes of reactive hyperemia-induced shear stress
(Figure 4A) to create an idealized experimental scenario:
comparison of five hypothetical "populations" with
known identical endothelial function but different mag-
nitude of reactive hyperemia-induced shear stress stimuli.
Our findings demonstrate that, when presenting the data
Table 1: Demographic characteristics of the subjects.
Variable Value
N2 0
Sex, M/W 10/10
Age, years 25.3 ± 0. 6
Height, cm 175.0 ± 2.1
Weight, kg 68.6 ± 2.5
Body mass index, Kg/m2 22.3 ± 0.4
Resting systolic blood pressure, mmHg 112.0 ± 2.6
Resting diastolic blood pressure, mmHg 71.4 ± 2.2
Total cholesterol, mg/dL 159.3 ± 7.2
High density lipoprotein cholesterol, mg/dL 57.2 ± 2.4
Low density lipoprotein cholesterol, mg/dL 89.1 ± 6.2
Triglycerides, mg/dL 64.9 ± 5.4
Fasting glucose, mg/dL 90.3 ± 1.5
High sensitivity C-reactive protein, mg/L 0.50 ± 0.1
Whole blood viscosity, mPa·s 3.74 ± 0.1
Hematocrit, % 42.9 ± 0.8
Reported physical activity1, days/week 4.3 ± 0.2
Values are mean ± SEM.
1 Aerobic physical activity of moderate intensity for 30 min or more.Cardiovascular Ultrasound 2008, 6:44 http://www.cardiovascularultrasound.com/content/6/1/44
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using the traditional approach (peak FMD), differences in
FMD are detected across the varying shear stimuli (Figure
4B), which would suggest the erroneous conclusion that
discrepancies in endothelial function exist among these
populations. However, when presenting the data using
the normalization approach (FMD:SSAUC ratio), these dif-
ferences are abolished (Figure 4C); thus confirming that
normalization of FMD to SSAUC eliminates the influences
of variable shear stress on measured conduit artery
endothelial function.
Pyke and Tshakovsky [16] were the first to examine the
effect of normalizing FMD to SSAUC. The purpose of their
study was to investigate the independent contributions of
the peak and continued reactive hyperemia-induced shear
stress on FMD. This was elegantly conducted by maintain-
ing the peak shear stimulus constant while manipulating
the shear stimulus duration (re-inflation of the cuff) or by
maintaining the shear stimulus constant while manipulat-
ing the magnitude of the peak shear stimulus (application
of arterial pressure). From these experiments, the authors
concluded that the SSAUC, but not the peak shear, was the
Table 2: Baseline hemodynamic information among forearm occlusion durations.
Variable 1-min 2-min 3-min 4-min 5-min p value
Arterial diameter, cm 0.352 ± 0.01 0.349 ± 0.01 0.349 ± 0.01 0.350 ± 0.01 0.350 ± 0.01 0.308
Blood velocity, cm • s-1 8.48 ± 1.9 8.99 ± 2.0 8.18 ± 1.8 8.81 ± 2.0 9.00 ± 2.0 0.67
Shear stress, dynes • cm-2 367.0 ± 32 392.4 ± 42 359.9 ± 32 385.1 ± 42 393.7 ± 40 0.648
Heart rate, bpm 51.5 ± 2 51.1 ± 2 52.5 ± 2 52.6 ± 2 52.4 ± 2 0.412
Forearm oxygen tissue saturation, % 56.87 ± 2.4 58.16 ± 2.3 58.46 ± 2.5 57.98 ± 2.5 58.41 ± 2.5 0.974
Values are means ± SEM. P value indicates the one-way ANOVA comparing the five baseline periods.
Time course of forearm oxygen tissue saturation (NIRS) in conjunction with brachial artery blood flow (ultrasound) Figure 3
Time course of forearm oxygen tissue saturation (NIRS) in conjunction with brachial artery blood flow (ultra-
sound). Values are means. *Volume of ischemia (StO2AUC) significantly different from all other trials; #Volume of ischemia 
(StO2AUC) significantly different from 3-min, 4-min, and 5-min; &Peak ischemia (StO2peak) significantly different from all other tri-
als; ^ Peak ischemia (StO2peak) significantly different from 1-min, 2-min, and 3-min. All p < 0.0001. Ultrasound data were not col-
lected during the occlusion periods.Cardiovascular Ultrasound 2008, 6:44 http://www.cardiovascularultrasound.com/content/6/1/44
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Reactive hyperemia-induced shear stress (panel A), peak FMD response (panel B), and FMD normalized to shear stress (panel  C) for the five occlusion conditions Figure 4
Reactive hyperemia-induced shear stress (panel A), peak FMD response (panel B), and FMD normalized to 
shear stress (panel C) for the five occlusion conditions. Values are means ± SEM. Panel A: *Magnitude of reactive hyper-
emia-induced shear stress (SS60secAUC) significantly different among all trials. Panel B: *Peak FMD significantly different from all 
other trials; #Peak FMD significantly different from 1-min, 2-min, and 5-min; &Peak FMD significantly different from 1-min and 2-
min; ^Peak FMD significantly different from 1-min, 2-min, and 3-min. All p < 0.0001.Cardiovascular Ultrasound 2008, 6:44 http://www.cardiovascularultrasound.com/content/6/1/44
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critical determinant of the peak FMD response; and thus
to be used for normalization purposes. Because their find-
ings were convincing and physiologically sound, we did
not consider further exploration of the relative contribu-
tion of peak vs continued shear. Instead, we opted to
manipulate the duration of cuff occlusion because this is
an effective method to globally modify the hyperemic
stimulus (both peak and duration); thus closely mimick-
ing real-life between-subject differences in shear.
The only two ultrasound studies manipulating the dura-
tion of cuff occlusion as strategy to create a range in hyper-
emic stimuli and assess the subsequent vasodilation
response at the conduit artery (radial and brachial) were
published in 1997 [23,24]. Both groups concluded that
the duration of hyperemic stimulus played an important
role on the vasodilatory response, observations that
prompted Pyke and Tshakovsky's study [16] 10 years later.
Our data are in agreement with Leeson et al. [24] and
Joannides et al. [23] in that longer duration of cuff occlu-
sion was associated with greater hyperemic and vasodila-
tion responses; however, these groups did not test
whether normalization of FMD to SSAUC removed differ-
ences among trials; this is not surprising as the concept of
FMD normalization was not introduced at that time. A
limitation to the studies of Leeson et al. and Joannides et
al. is the utilization of blood flow, instead of shear stress,
as representation of the vasodilatory stimulus. Unfortu-
nately, blood flow (velocity ￿ π ￿ (diameter2/4) ￿ 60) and
shear stress (viscosity ￿ 4 ￿ velocity/diameter) are parallel
only in conditions where arterial diameters are constant,
a situation that does not occur during the hyperemic
phase where arterial diameters are significantly and
dynamically altered. Furthermore, in contrast to Leeson et
al. and Joannides et al., our study incorporated the NIRS
technology to quantify the magnitude (volume and peak)
of forearm occlusion-induced ischemia. Given that the
forearm ischemia is the driving force for reactive hypere-
mia, characterization of the principal stimulus for FMD
should not be neglected.
There are a few limitations to this study. First, because all
trials were performed on the same day, it is possible that
repeated episodes of ischemia-induced hyperemia influ-
enced subsequent measures; however evidence suggests
that serial FMD measurements do not affect subsequent
FMD outcomes [19]. We chose to include all trials on one
day in order to avoid day-to-day endothelial function var-
iability [25] and to allow for consistent placement of the
ultrasound and NIRS probes across trials, which mini-
mizes these recognized sources of variability in these
measurements. Sufficient time was allowed between trials
for diameters, velocities, and tissue oxygen saturation to
reach baseline values. Most importantly, the order of trials
was randomized to minimize any confounding influence
from this potential carry-over effect. Second, although the
dilation following the conventional 5-min forearm occlu-
sion is largely attributed to NO[3,4], it remains unknown
if dilation following shorter periods of occlusion (1, 2, 3,
and 4 min) is NO dependent as well. In addition, the
effects of reduced shear and/or metabolites released dur-
ing the ischemic period on the FMD response are not well
understood, thus manipulation of occlusion duration
may be considered a limitation to the study. Third, our
measurements of whole blood viscosity were performed
using a glass capillary viscometer, thus we were unable to
assess viscosity at varying shear rates. Although we
believed that measurements of viscosity using this
method would provide more accurate shear stress infor-
mation than using a constant (assumed) viscosity of 4
mPa ￿ s for all subjects [26], there were no differences
between both approaches (Table 3). This observation sug-
gests that the addition of viscosity measurements does not
have a significant impact on shear stress calculations and
it does not alter the interpretation of the FMD results. The
validity of our viscosity measures may be demonstrated by
the small coefficient of variation (4.47 ± 0.65%) and high
correlation between hematocrit and viscosity (r = 0.878, p
< 0.001). Fourth, because our sample was composed of 20
healthy asymptomatic men and women, extrapolation of
these findings across clinical populations should be made
with caution.
Table 3: Shear stress area under the curve calculated using measured viscosity vs. assumed viscosity.
Shear stress area under the curve (a.u.)
Measured viscosity used Assumed viscosity (4 mPa·s) used t-test p value ICC coefficient (p value)
1-min 11.7 ± 1.3 12.7 ± 1.5 0.610 0.985 (< 0.0001)
2-min 20.0 ± 1.4 21.7 ± 1.7 0.457 0.950 (< 0.0001)
3-min 26.3 ± 1.6 28.7 ± 2.2 0.386 0.941 (< 0.0001)
4-min 35.4 ± 2.1 38.3 ± 2.5 0.377 0.930 (< 0.0001)
5-min 41.5 ± 2.2 45.0 ± 2.8 0.340 0.919 (< 0.0001)
Values are means ± SEM.
ICC = Intraclass correlationCardiovascular Ultrasound 2008, 6:44 http://www.cardiovascularultrasound.com/content/6/1/44
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Conclusion
The significance of the present findings is notable. Our
results support the view of Pyke and Tschakovsky [16], the
original advocates of FMD normalization to SSAUC
approach. The obvious lack of compliance to the recent
guidelines in the clinical literature is intriguing and per-
haps problematic. From a theoretical and physiological
standpoint, there is robust evidence that FMD should be
corrected by its dilator stimulus; however, the following
question remains to be resolved: Does FMD:SSAUC ratio
predict cardiovascular risk and events more accurately
than peak FMD (the traditional FMD approach)? Further
research is warranted to confirm that the apparent physi-
ological appropriateness of normalization is in fact clini-
cally pertinent. Given that arterial diameter and velocity
measurements are typically performed continuously and
simultaneously during the hyperemic phase, we encour-
age investigators to, at the minimum, report FMD data
using both the traditional (peak FMD response) and nor-
malization (peak FMD:SSAUC ratio) approaches. In sup-
porting this new approach, while we do not intend to
invalidate the large body of evidence collected using the
traditional FMD approach, we advise the reader to inter-
pret the existing literature with caution. Special attention
should be devoted to studies that did not report any form
of hyperemic stimulus.
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